Paul Bo San Lai (Paul Bo-San Lai)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Patient Reported

Oxidative Stress

Helicobacter Pylori

Top Venues

Annals of hepato-biliary-pancreatic surgery

Science translational medicine

Chinese University of Hong Kong

Northumbria University School of Law (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Chinese University of Hong Kong

Hong Kong

Professor :: Surgery

Education History

Northumbria University School of Law

United Kingdom

MSC

Chinese University of Hong Kong

Hong Kong

PHD

Publications

Kit-Fai Lee, Janet Wui Cheung Kung, Andrew Kai Yip Fung, Hon-Ting Lok, Charing Ching Ning Chong, John Wong, Kelvin Kwok-Chai Ng, Paul Bo San Lai
A case series of emergency pancreaticoduodenectomies: What were their indications and outcomes? Annals of hepato-biliary-pancreatic surgery (2023)
Weiqin Yang, Yu Feng, Jingying Zhou, Otto Ka-Wing Cheung, Jianquan Cao, Jing Wang, Wenshu Tang, Yalin Tu, Liangliang Xu, Feng Wu, Zhiwu Tan, Hanyong Sun, Yuan Tian, John Wong, Paul Bo San Lai, Stephen Lam Chan, Anthony Wing-Hung Chan, Patrick Boon-Ooi Tan, Zhiwei Chen, Joseph Jao Yiu Sung, Kevin Yuk-Lap Yip, Ka-Fai To, Alfred Sze-Lok Cheng
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma. Science translational medicine 13 (588) (2021)
Jianqing Yu, Nuozhou Wang, Zhongqin Gong, Liping Liu, Shengli Yang, George Gong Chen, Paul Bo San Lai
Cytochrome P450 1A2 overcomes nuclear factor kappa B-mediated sorafenib resistance in hepatocellular carcinoma. Oncogene 40 (3) (2020)